|
EIF4G3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.050400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438000E-01 |
| Normal-vs-Stage2 |
3.408000E-01 |
| Normal-vs-Stage3 |
5.281000E-01 |
| Normal-vs-Stage4 |
5.406800E-01 |
| Stage1-vs-Stage2 |
8.056600E-01 |
| Stage1-vs-Stage3 |
4.736600E-01 |
| Stage1-vs-Stage4 |
7.607600E-01 |
| Stage2-vs-Stage3 |
7.290400E-01 |
| Stage2-vs-Stage4 |
9.093800E-01 |
| Stage3-vs-Stage4 |
8.824400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.127000E-01 |
| Normal-vs-AfricanAmerican |
1.588160E-01 |
| Normal-vs-Asian |
5.416600E-01 |
| Caucasian-vs-AfricanAmerican |
6.991600E-01 |
| Caucasian-vs-Asian |
9.367400E-01 |
| AfricanAmerican-vs-Asian |
8.607400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.732410E-02 |
| Normal-vs-Female |
3.760400E-01 |
| Male-vs-Female |
3.205300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.103800E-01 |
| Normal-vs-Extreme_Weight |
3.178100E-02 |
| Normal-vs-Obese |
4.469000E-01 |
| Normal-vs-Extreme_Obese |
2.300400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.178800E-01 |
| Normal_Weight-vs-Obese |
6.110400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.351400E-01 |
| Extreme_Weight-vs-Obese |
6.589600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.316000E-01 |
| Obese-vs-Extreme_Obese |
4.447200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.416200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.953400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.466300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.484450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.955000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.367700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.078100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.883800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.216600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.030300E-02 |
| Normal-VS-Type2 PRCC |
1.677210E-01 |
| Normal-VS-KIRP CIMP |
3.258300E-02 |
| Normal-VS-Unclassified PRCC |
9.881800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.790000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.84460000000653E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.683600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.923100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.623990E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.611600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.793900E-02 |
| Normal-vs-N1 |
8.043200E-01 |
| Normal-vs-N2 |
8.933600E-01 |
| N0-vs-N1 |
4.418300E-02 |
| N0-vs-N2 |
2.181600E-01 |
| N1-vs-N2 |
7.912200E-01 |
|
|
